San Diego · Fractional CFO
Staxiom folds cash-flow guidance, capital strategy, and board-ready numbers into our top advisory tier for San Diego startups, built for the years-long, grant-funded runway a lot of local biotech companies run on.
Real numbers on burn and runway for grant-funded, pre-revenue companies.
Numbers built for a board or investor update, not reformatted the night before.
Structure and timing calls made before a deadline forces them.
A clinical-stage company can run for years without revenue, funded entirely by grants and investor capital, which makes an accurate runway model the difference between raising the next round on a founder's own timeline versus being forced into one under pressure. That's the core of what's folded into the top advisory tier alongside bookkeeping and tax filing.
Read the full breakdown on the fractional CFO guidance page, or see how this looks for Los Angeles and Orange County startups.
Clinical-stage biotech companies often run for years without revenue, funded entirely by grants and investor capital, which makes an accurate runway model the difference between raising the next round on a founder's own timeline versus being forced into one under pressure. That's the core of what's folded into Staxiom's top advisory tier alongside bookkeeping and tax filing.
The same as everywhere else Staxiom works: folded into the top advisory tier starting at $1,500/month rather than sold as a separate standalone fee, regardless of city or industry.
Add your revenue and website for a full review, reviewed by a CPA who ran EY's West Coast R&D Tax Credit practice for 13 years.